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a b s t r a c t
Background: In order to conduct laboratory studies on donated cervical tissue at suitable times an
effective and reliable cryopreservation protocol for cervical tissue is required.
Methods: An active freezing approach was devised utilising 10% dimethyl sulfoxide in foetal bovine
serum as a cryoprotective agent with a cooling rate of 1 C/min to 50 C then 10 C/min to 120 C; a
related thawing protocol was also optimised which would allow for the bio-banking of cervical tissue.
Viability of freshly harvested cervical tissue was compared to frozen-thawed samples utilising colori-
metric MTT assay. In parallel, fresh and freeze-thawed samples were cultured and tested on days 1, 7 and
14 to determine whether bio-banking had detrimental effects on tissue viability over time.
Results: Repeat testing revealed that tissue viability between fresh and freeze-thawed samples was
comparable at all four time points (days 0, 1, 7 and 14) with no apparent reductions of viability, thus
demonstrating this method of cryopreserving cervical tissue is reliable and reproducible, without
detrimental effects on live tissue culture. We believe this methodology creates the opportunity for bio-
banking donated cervical tissues, which aids improved experimental design and reduces time pressures
and wastage.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Extensive scientiﬁc literature has reported the utilisation of
cervical tissue organo-typical models to further our understanding
of HIV transmission and to aid development of potential thera-
peutic interventions [12,15]. We are also aware of cervical explants
being utilised to study mucosal epithelial cell differentiation and
leukocyte inﬁltration [10], cytomegalovirus infection studies [6]
and for vaccine research [2]. Almost exclusively, these studies and
others were undertaken in fresh tissue transported without delay
from hospitals to scientiﬁc laboratories for immediate use in
experimental procedures. We aimed to conduct Human T-lym-
photropic virus (HTLV)-1 ex vivo infection studies in donated cer-
vical tissue from women who had undergone hysterectomies, to
mimic physiological in vivo infection via the sexual contact route to
extend our knowledge beyond more simple cell-cell infection
studies; readily available tissue would be beneﬁcial.
We utilised published protocols to establish an ex vivo organo-
typical model for cervical tissue explants [3] aiming to co-culture
HTLV-1 with live cervical explants. However, to facilitate reliable
and reproducible studies of tissue co-cultures from the same donor
at convenient time points and for purposes of long term storage of
tissue for bio-banking, we sought to establish a protocol for cervical
tissue cryopreservation akin to those validated for the bio-banking
of other tissues, such as tonsils [11]. Here, we demonstrate that
using the proposed protocol, cryopreserved cervical tissue can be
thawed with minimal loss of tissue viability compared to fresh
explants. We believe the development of this reproducible meth-
odology permits long-term cervical tissue storage, thus reducing
waste of precious tissue donations and, with relevant ethical
approval in place, allows for cervical tissue bio-banking and tissue
exploitation for a variety of studies.
2. Materials and methods
2.1. Ethics and tissue preparation
UK National Research Ethics Service (NRES 11/YH/0321),
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Research & Development at York Teaching Hospital NHS founda-
tion Trust (YORA01992) and University of York ethically approved
the study of ex vivo HTLV-1 cervical explant co-culture studies.
Written informed consent was obtained from women with normal
cervical smears who needed to undergo a planned hysterectomy for
their own health and who were willing to donate cervical tissue.
After the hysterectomy the uterus was transported to the histopa-
thology department and reviewed macroscopically by the consul-
tant histopathologist. Approximately 90% of the healthy cervix was
released for research purposes.
Cervical tissue was immediately transferred into transportation
medium (Leibovitz's L-15 medium containing heat-inactivated
single-batch 10% foetal bovine serum (FBS), 100 U/ml penicillin,
100 mg/ml streptomycin, and 2.5 mg/ml amphotericin B [all from
Invitrogen]) and cooled at 4 C for transportation to research lab-
oratories. All samples underwent processing within 4 h of surgery.
Endo- and ecto-cervix were separated and all tissues were cut into
approximately 1 cm3 explants containing mucosal and submucosal
tissue to maintain tissue architecture. Tissue explants were either
immediately processed for laboratory studies and tissue viability
assays on explant pieces deﬁned as day 0 (d0), or cryopreserved for
subsequent testing.
2.2. Tissue freezing
Cervical explants (~1 cm3) that were not immediately studied
were placed individually into 2 ml cryovials on ice containing 1 ml
of pre-cooled (4 C) freezing medium (90% FBS with 10% dimethyl
sulfoxide (Me2SO)) that was displaced by the explant ensuring
cryoprotectant reached all the tissue. Cryovials were rapidly
transferred to a control rate freezer pre-cooled to 4 C (Planer
KRYO560-16, Planer PLC, Sunbury-on-Thames, UK) and explants
were cooled from 4 C to 50 C at 1 C/min and then from 50 C
to 120 C at 10 C/min before transfer to liquid nitrogen for long
term cryopreservation and bio-banking. Freezer chamber temper-
ature datawas recorded as evidence of successful cycle completion.
2.3. Tissue thawing
For this study, cervical explants were banked for an average of
189 days (range 119e236 days) before frozen tissue was thawed by
cryovial retrieval from liquid nitrogen and immediate immersion in
a water bath at 37 C. As soon as freezing medium had started to
thaw, the explant and thawed freezing medium was transferred,
using forceps if necessary, to be completely submerged in 15 ml of
pre-warmed (37 C) culture medium (Roswell Park Memorial
Institute 1640 medium containing heat-inactivated single-batch
10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, all from
Invitrogen) in 6-well plates in a sterile environment. Each explant
was left undisturbed in this medium for 10 min at 37 C in a hu-
midiﬁed environment supplied with 5% CO2 in air before three
further successive transfers to 15 ml of fresh culture medium,
incubating for 10 min in each aliquot of 15 ml medium for a total
time of 40 min. Tissue viability testing was immediately performed
on explant pieces and deﬁned as d0.
2.4. Tissue viability testing
We tested the viability of fresh and frozen-thawed cervical ex-
plants on the deﬁned day 0 and after 1, 7 and 14 days in culture.
Each cervical explant was cut up into at least 12 roughly equal-sized
small pieces; individual explant pieces were transferred to single
wells on a 96 well plate and covered with 200 ml culture medium
before immediate testing or culture. Medium was changed every 3
days by removal of 170 ml of medium and replacement with 200 ml
of fresh culture medium; empty wells were ﬁlled with medium to
reduce evaporation. An MTT assay was used to establish general
tissue viability by measuring the intensity of purple colour pro-
duced through mitochondrial oxidoreductase reduction of the MTT
tetrazolium dye to its insoluble formazan, as described previously
[14]. A 50 ml solution of Thiazolyl Blue Tetrazolium Bromide
(Sigma-Aldrich, UK) [MTT] was prepared at 250 mg/ml in Roswell
Park Memorial Institute 1640 medium and ﬁltered through a
0.2 mm ﬁlter; 1 ml per well of this solution was aliquoted into three
wells of a 48 well plate at each time point. A piece of explant was
incubated with the 1 ml of MTT for 3 h under standard tissue cul-
ture conditions, in triplicate. After this incubation, tissue was
transferred to 1 ml of methanol for dye elution and incubated for
16 h. Explants were removed and left to dry for 24 h, to increase
accuracy, before weighing. Two-hundred ml of the tissue eluate in
methanol was transferred in triplicate to a 96 well plate before
optical density (OD) readings were taken at 595 nm (VersaMax
plate reader, Molecular Devices, Wokingham, UK). Triplicate OD
readings for methanol alone were made in parallel before sub-
traction from each sample OD followed by averaging of the tripli-
cate readings for each piece of tissue. Tissue pieces were dried
overnight before weight corrected OD (wcOD) was calculated using
the formula: average OD reading/dried tissue weight (grams). The
percentage metabolic activity as a measure of tissue viability was
calculated by dividing the wcOD of each sample at each time point
(day 0, 1, 7 and 14) by the averaged wcOD of triplicate pieces of
tissue at day 0. We compared the wcOD of 10 fresh and three
freeze-thawed tissues at day 0, 1, 7 and 14 to establish a quality
control protocol for the cryopreservation of cervical tissue.
2.5. Explant sectioning and staining
Cervical tissue (fresh or freeze-thawed) after 1 day in culture
was snap frozen in O$C.T. (Agar Scientiﬁc, Stansted, UK) on spec-
imen discs (Leica, Loughborough, UK) seated on dry-ice then
transferred to a 80 C freezer. The blocks were sectioned (5 mm
sections) using an OTF5000 cryostat microtome (Bright In-
struments Ltd. Luton, UK), and applied to poly-lysine coated glass
slides (Fisher Scientiﬁc, Loughborough, UK). Air-dried sections
were haematoxylin and eosin (H&E) stained by immersing into
ﬁltered Mayers haematoxylin (Sigma-Aldrich, Poole, UK) for 5 min
then rinsed in running tap water for an additional 5 min before
dipping twelve times in 0.5% Eosin (Sigma-Aldrich). Sections were
washed again in distilled water then dehydrated by dipping in
sequential ethanol baths (50%, 70%, 95% and 100% EtOH) for be-
tween 30 and 60 s in each bath. Slides were air-dried and mounted
using minimal DePeX (Sigma-Aldrich), a toluene-xylene-based
mounting compound, and a coverslip. Sections were tile-scan
imaged using a 10 objective on an Olympus B51 microscope
and MagnaFire SP software (Olympus, Southend-on-Sea, UK)
before composite images were constructed in Photoshop (Adobe,
Maidenhead, UK).
3. Results
From 19 separate cervical donations we were able to obtain, on
average, 14 ± 6 explants of cervical tissue measuring approximately
1 cm3 that was identiﬁed by morphology as 1 ± 2 explants of
endocervix and 13 ± 6 ectocervix explants (Supplementary
Table 1). Explants surplus to experimental requirements were
prepared and frozen as outlined and data recordings from the
control rate freezer showed that the freezing process proceeded
uninterrupted (data not shown). Using the protocols detailed above
we performed viability assays at d0 on all cervical donations as well
as on three randomly selected frozen/thawed-cervical tissue
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explants. These explants had been frozen for a mean of 189 days
(range 119e236 days) and were thawed as described to coincide
with the availability of a freshly harvested cervical explant. Viability
assays were performed on pieces of the thawed explants and pieces
of the fresh explant at this day 0 time point. Explant piece sizes
were not signiﬁcantly different in size (P > 0.05 using t-test), with
fresh explants having a mean piece weight of 7.8 ± 0.7 mg and
frozen-thawed pieces being 5.2 ± 0.4 mg. Remaining pieces of the
same explants were then cultured in triplicate for 1, 7 and 14 days
for additional viability assays. At all time points, macroscopically,
both fresh and frozen tissue appeared similarly viable with both
developing a purple colouring after incubation with the MTT
reagent.
The mean optical density at day 0 of ten randomly selected fresh
explants after weight correction was pooled and found to be
78.39 ± 11.79. The mean wcOD of the control fresh tissue used for
this direct comparison studywas 80.27 ± 9.80 and the three frozen-
thawed triplicated explants had a wcOD of 82.60 ± 7.80
(Supplementary Table 2). No signiﬁcant difference (P ¼ 0.29) in
metabolic activity (wcOD) as a measure of tissue viability was
detectable between the pooled fresh- and thawed-explants at d0,
using a t-test. Fig. 1 shows the viability of the three thawed explants
compared to seven fresh samples during subsequent culture at days
1, 7 and 14; data is expressed as a percentage of the respective
explant's wcOD at day 0. As can been observed, the viability of only
one of the freeze-thawed explants was noticeably decreased from
fresh tissue at days 1 and 7 whilst at day 14 even explant from
donor 1 had similar viability to the fresh tissue (Fig. 1). No signiﬁ-
cant differences were found between the pooled tissue viability at
d0 and the frozen-thawed tissue viability at d1, d7 or d14 using
one-way ANOVA and Dunnett's Multiple Comparison Test.
Furthermore, cervical explant pieces were sectioned, H&E
stained and imaged to demonstrate that both frozen-thawed
(Fig. 2) and fresh (Supplementary Fig. 1) tissue had acceptable
morphology and had not been affected by tissue processing for
culture and cutting into 1 cm3 explants for convenient storage in
our bio-banking freezing procedure and subsequent thawing. The
two images are comparable, although the eosin stain is a little more
intense in the image of frozen-thawed tissue, clearly demonstrating
that frozen-thawed tissue appears just as viable as fresh tissue.
4. Discussion
The rationale for this study was our desire to perform viral
infection studies using ex vivo human cervical tissue replicating
in vivo HTLV infections, which required the establishment of an
organo-typical model. In order to conduct laboratory studies at
convenience without losing previous cervical tissue we needed to
store tissue long-term without a signiﬁcant detrimental effect on
tissue viability. Herein we describe the methodology used for the
preparation, cryopreservation, bio-banking and thawing of cervical
explants, which results in metabolically viable andmorphologically
intact tissue amenable for further experimentation. Our protocol is
reliable and reproducible in preserving tissue viability.
Cervical tissue freezing and viable recovery has seldom been
described in detail though Gupta et al., brieﬂy communicated a
method during their development of a cervical tissue-derived or-
gan culture model [4]. Gupta and colleagues, using haematoxylin
and eosin staining, showed that fresh as well as frozen-thawed
cervical tissue maintained its integrity. In addition, they showed
that therewere no signiﬁcant differences in the expression levels of
cytokeratin and Ki67, two non-immune cellular markers, using
immunohistochemistry. Furthermore, they demonstrated that both
fresh and freeze-thawed tissue supported HIV-1 transmission and
were equally useful for testing antiretroviral compounds. Our
studies of tissue viability complement these ﬁndings and add
important additional evidence, in addition to more comprehensive
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Fig. 1. MTT assay comparison of fresh and freeze-thawed cervical tissue explant viability. The mean viability of seven fresh cervical explants (each performed in triplicate at
every time point) compared to that of freeze-thawed cervical explants from three separate donors (in triplicate) at days 0, 1, 7 and 14 days assessed by MTT assay is shown. Average
viability over time is expressed as a percentage of the respective explant's viability at day 0 ± SEM.
Fig. 2. Representative cervical tissue H&E staining of freeze-thawed cervical tissue.
Composite representation of sequential images of an H&E stained section of cervical
tissue that had been frozen, cryopreserved, thawed then cultured to d1.
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and reproducible methodology.
The major methodological differences between our approach
and the study of Gupta et al., are that Gupta and colleagues
examined cervical tissue that had been snap frozen in liquid ni-
trogen and stored at 80 C using methodology described by the
research group on a previous occasion [13]. Conversely to Gupta
et al., in this study tissue was divided into 1 cm3 explants for
convenient storage in cryovials, which had no signiﬁcant delete-
rious effects on tissue viability or tissue integrity. We believe seg-
menting donated cervical tissue for long-term storage or bio-
banking will prove more efﬁcient than whole tissue storage since
individual explants (an average of 14  1 cm3 explants can be ob-
tained from representative donations) rather than the whole tissue
can be thawed for future studies.
We used a slow freezing method, employed Me2SO as a cryo-
protective agent (CPA) and stored our frozen cervical tissue in liquid
nitrogen (approximately 196 C) as opposed to the snap freezing
procedures and storage at 80 C described by previously [13]. We
favoured this slow cryopreservation since we wished to store small
segments of cervical donation and determined that the smaller
tissue size would be suitable for the slow freezing process favoured
for the cryopreservation of cell lines [5], where the employment of
a freezing rate of 1 C/min to50 C then 10 C/min to120 C has
been demonstrated to be the optimal cooling rate for mammalian
cells [7]. We employed an active freezing approach through the
utilisation of a control-rate freezer as this produces a more accurate
and reproducible freezing rate that can be calibrated and freezing
data can be recorded to ensure it has proceeded accordingly. This
allowed recordability and afforded equipment calibration, which
are important requirements for good laboratory practice and efﬁ-
cient bio-banking.
Due to its rapid permeability we used Me2SO as our CPA to
protect cervical explant cells against intracellular and extracellular
ice crystal formation during freezing [9]. We used 10%Me2SO in FBS
that, although debatable, has previously been shown to have low
toxicity [1]. The FBS that was used in our study was, for experi-
mental consistency, heat-inactivated and from a single batch.
Finally, we chose to store the frozen cervical explants at 196 C in
liquid nitrogen because this temperature provides greater stability
to tissue biospecimens than storage at higher temperatures, likely
due to the glass transition temperature of water being 135 C [7].
Whilst previously reported cryopreservation methods are
effective [4,13], in our opinion, neither study provides sufﬁcient
detail for straightforward replication. Also, it is not clear how long
their tissue had been frozen before it was thawed again, which
made it difﬁcult to assess any effect of long-term cryopreservation.
The additional beneﬁt of this study is therefore the provision of a
comprehensive methodology for cervical tissue freezing and
thawing and demonstrating that cervical tissue can be frozen for at
least 236 days without any noticeable loss of tissue viability. Our
study also provides useful details that, to our knowledge, have not
been mentioned elsewhere, such as the number and amount of
tissue that is likely to be available from cervical tissue donations
(Supplementary Table 1).
Study limitations are that we didn't directly compare different
methods of freezing and thawing. We considered that it would be
ethically difﬁcult to rationalise the additional usage of precious
tissue having found a methodology that had little impact on tissue
viability and architecture. Scientiﬁcally it would be interesting to
directly compare the effects of different lengths of time from har-
vest to processing, different lengths of freezing, slow-versus snap-
freezing, various CPAs and active versus passive freezing on the
viability and integrity of stored cervical tissue. Active freezing
processes may not be available to all laboratories; passive freezing
approaches utilise economical, commercially available freezing
containers ﬁlled with isopropanol, such as a Mr Frosty freezing
container. These devices implement a cooling rate of 1 C per
minute when placed in a 80 C freezer. If the device is left un-
disturbed and the isopropanol is changed frequently to avoid loss of
alcohol through evaporation, as per manufacturer guidelines, pas-
sive freezing may be employed in the absence of a control-rate
freezer. Janz Fde et al., reported that both approaches display
similar potential to maintain phenotype, viability and function of
certain tissue [8]. Finally, our methodology may be unsuitable for
whole tissue freezing of cervical tissue should a larger sized sample
be required.
To conclude, long-term cryopreservation of cervical explants is
important to reduce tissue wastage and help with convenient
planning of laboratory research without affecting research quality
and to allow the preservation of surplus tissue for long-term bio-
banking for future ethically approved ex vivo cervical explant
studies. Herein we provide a detailed and extensive reproducible
methodology to support this goal.
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